Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001179110-11-015251

Options or other derivatives

  • Director acquired 82,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

RECTOR DAVID · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2011-11-16 Grant or award : show line 1 in the form Common Stock Option +82,500 $0.20 2021-11-16 82,500 1,004,297 D
Loading xslF345X03/edgar.xml…